Trials / Completed
CompletedNCT05468385
The Effects of taVNS on Inhibitory Control
Transcutaneous Auricular Vagus Nerve Stimulation Improves Inhibitory Control in Emotional Go-Nogo Task
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- University of Electronic Science and Technology of China · Academic / Other
- Sex
- All
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
The main aim of the study is to investigate whether the transcutaneous vagus nerve stimulation(tVNS) improves the ability of inhibitory control in an emotional Go-Nogo task.
Detailed description
A randomized, sham-controlled, between-subject design will be employed in this study. A total of 87 healthy subjects will receive either transcutaneous vagus nerve stimulation via tragus or sham stimulation via the earlobe in the left ear. Brain activity and behavioral data for an emotional Go-Nogo task will be recorded and saliva samples will be collected before, during, and after stimulation. Some personal traits will be assessed using different kinds of questionnaires, such as the State-Trait Anxiety Inventory (STAI), Beck's Depression Inventory(BDI), Autism Spectrum Quotient (ASQ) et al.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vagus nerve stimulation via tragus | The device will send stimulus intensity of around 0.5mA via tragus in the left ear (based on participants' subjective report), delivered with a pulse width of 0.5 ms at 25 Hz. Stimulation will be active for 30 seconds, followed by a break of 30 seconds. |
| DEVICE | Sham stimulation via earlobe | The device will send stimulus intensity of around 0.5mA via the earlobe in the left ear (based on participants' subjective reports), delivered with a pulse width of 0.5 ms at 25 Hz. Stimulation will be active for 30 seconds, followed by a break of 30 seconds. |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2022-07-20
- Completion
- 2022-08-05
- First posted
- 2022-07-21
- Last updated
- 2023-12-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05468385. Inclusion in this directory is not an endorsement.